Poket News

CCRAS transfers Ayush-64 drug technology to 46 companies

 

  • The Central Council for Research in Ayurvedic Sciences (CCRAS) has transferred the technology of Ayush-64 to 46 companies. Ayush-64 is an effective drug in mild and asymptomatic and mild to moderate cases of COVID-19. 
  • The Ministry of Ayush said that before the first wave of COVID, 7 companies including IMPCL, the manufacturing unit of the Ministry of Ayush, were responsible for manufacturing Ayush-64. 
  • It said, now the technology has been transferred to 39 companies, taking this figure to 46.